The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Postural Tachycardia Syndrome (POTS)
Open accessAbstract
Postural Tachycardia Syndrome. Introduction: POTS is defined as the development of orthostatic symptoms associated with a heart rate (HR) increment ≥30, usually to ≥120 bpm without orthostatic hypotension. Symptoms of orthostatic intolerance are those due to brain hypoperfusion and those due to sympathetic overaction. Methods: We provide a review of POTS based primarily on work from the Mayo Clinic. Results: Females predominate over males by 5:1. Mean age of onset in adults is about 30 years and most patients are between the ages of 20–40 years. Pathophysiologic mechanisms (not mutually exclusive) include peripheral denervation, hypovolemia, venous pooling, β‐receptor supersensitivity, psychologic mechanisms, and presumed impairment of brain stem regulation. Prolonged deconditioning may also interact with these mechanisms to exacerbate symptoms. The evaluation of POTS requires a focused history and examination, followed by tests that should include HUT, some estimation of volume status and preferably some evaluation of peripheral denervation and hyperadrenergic state. All patients with POTS require a high salt diet, copious fluids, and postural training. Many require β‐receptor antagonists in small doses and low‐dose vasoconstrictors. Somatic hypervigilance and psychologic factors are involved in a significant proportion of patients. Conclusions: POTS is heterogeneous in presentation and mechanisms. Major mechanisms are denervation, hypovolemia, deconditioning, and hyperadrenergic state. Most patients can benefit from a pathophysiologically based regimen of management. (J Cardiovasc Electrophysiol, Vol. 20, pp. 352‐358, March 2009)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These symptoms may be accompanied by hemodynamic disturbances, including blood pressure decrease, which may or may not meet criteria for OH, and heart rate increase, which may be inadequate or compensatory (38).”
From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most commonly, the symptoms include lightheadedness, palpitations, tremulousness, generalized weakness, blurred vision, exercise intolerance, and fatigue.”
From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another large subgroup within the POTS population is the so-called hyperadrenergic subtype, with features that may correspond to 30% to 60% of POTS patients (6,36,37).”
From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients with hyperadrenergic POTS or significant hypertensive responses during tilt may respond to phenobarbital 15 mg in the morning and 60 mg at night (36).”
From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [36]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The standing (or orthostatic) heart rate of individuals with POTS is often ≥120 bpm,8–13”
The cited source says what the claim attributes to it.
In the citing paper
“and more than 75% are female.7–9,11–14,16”
The cited source says what the claim attributes to it.
In the citing paper
“These patients have elevated standing plasma norepinephrine (NE) levels (>600 pg/ml), reflecting an exaggerated sympathetic response (6,36),”
From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“Clonidine (a central sympatholytic) 0.1 mg twice daily can be used to reduce autonomic instability in similar patients (36).”
From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [36]
In the citing paper
“Estimates, based largely on clinical experience, range from 0.2% and 1% of the US population, which would suggest approximately 1–3 million affected persons (Arnold et al., 2018; Low et al., 2009; Sheldon et al., 2015).”
From Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1 (2021) · cites this paper as Low et al., 2009
In the citing paper
“These patients may have orthostatic hypertension (increase in systolic blood pressure >10 mmHg on standing) and complain of tremor, anxiety and cold, sweaty extremities [7;25].”
From Postural tachycardia syndrome: beyond orthostatic intolerance (2015) · cites this paper as [25]
In the citing paper
“In addition to orthostatic symptoms in POTS, patients experience non-specific signs and symptoms that seem unrelated to postural intolerance or excessive tachycardia [25].”
From Postural tachycardia syndrome: beyond orthostatic intolerance (2015) · cites this paper as [25]
In the citing paper
“The vast majority are young, with a mean age of presentation between 15–3034,36.”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [36]
In the citing paper
“POTS has been shown to have a prevalence of 0.2% in cohort studies31–33 and predominately affects females at a 5:1 ratio.31,34–36”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [36]
In the citing paper
“POTS is excessive sinus tachycardia triggered by minimal physical activity, especially movement to upright posture.36,50,125,171”
From Sinus Tachycardia: a Multidisciplinary Expert Focused Review (2022) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rossi, P., Andriesse, G. I., Oey, P. L., Wieneke, G. H., Roelofs, J. M. M., & Akkermans, L. M. A. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00276-7 · Cited by 767
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D., Farrugia, G., & Lennon, V. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431204 · Cited by 674
Self-citationIdiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia?
Schondorf, R., & Low, P. A. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.132 · Cited by 548
Self-citationPostural orthostatic tachycardia syndrome: the Mayo clinic experience
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Low, P. A., Lennon, V. A., & Shen, W.-K. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61027-6 · Cited by 516
Self-citationThe neuropathic postural tachycardia syndrome
Jacob, G., Costa, F., Shannon, J. R., Robertson, R. M., Wathen, M., Stein, M., Biaggioni, I., Ertl, A., Black, B., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431404 · Cited by 398
The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome
Bou-Holaigah, I. (1995) · JAMA · doi:10.1001/jama.1995.03530120053041 · Cited by 384
Low, P. A., & Benarroch, E. E. (2009) · Cited by 344
Self-citationThe Pressor Response to Water Drinking in Humans
Jordan, J., Shannon, J. R., Black, B. K., Ali, Y. S., Farley, M., da Costa, F. A. A., Diedrich, A., Robertson, R. M., Biaggioni, I., & Robertson, D. (2000) · Circulation · doi:10.1161/01.cir.101.5.504 · Cited by 342
Postural tachycardia syndrome (POTS)
Lamotte, G., & Low, P. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85492-4.00118-6 · Cited by 301
Self-citationDelayed orthostatic hypotension: A frequent cause of orthostatic intolerance
Gibbons, C. H., & Freeman, R. (2006) · Neurology · doi:10.1212/01.wnl.0000223828.28215.0b · Cited by 286
Thermoregulatory Sweating Abnormalities in Diabetes Mellitus
Fealey, R. D., Low, P. A., & Thomas, J. E. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65338-5 · Cited by 274
Self-citationEl-Sayed, H., & HAINSWORTH, R. (1996) · Heart · doi:10.1136/hrt.75.2.134 · Cited by 261
Water drinking as a treatment for orthostatic syndromes
Shannon, J. R., Diedrich, A., Biaggioni, I., Tank, J., Robertson, R. M., Robertson, D., & Jordan, J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01025-2 · Cited by 233
Water drinking acutely improves orthostatic tolerance in healthy subjects
Schroeder, C., Bush, V. E., Norcliffe, L. J., Luft, F. C., Tank, J., Jordan, J., & Hainsworth, R. (2002) · Circulation · doi:10.1161/01.cir.0000038921.64575.d0 · Cited by 227
Autonomic Nervous System Function
Low, P. A. (1993) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199301000-00003 · Cited by 215
Self-citationA potent pressor response elicited by drinking water
Jordan, J., Shannon, J. R., Grogan, E. L., Biaggioni, I., & Robertson, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)99015-3 · Cited by 195
Postural Tachycardia Syndrome: Clinical Features and Follow-up Study
Sandroni, P., Opfer-Gehrking, T. L., McPhee, B. R., & Low, P. A. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.11.1106 · Cited by 194
Self-citationStreeten, D. H. P., Anderson, G. H., Richardson, R., & THOMAS, F. D. (1988) · PubMed · Cited by 183
Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A., & Robertson, D. (2005) · Circulation · doi:10.1161/circulationaha.104.497594 · Cited by 171
Blood pressure recovery from Valsalva maneuver in patients with autonomic failure
Vogel, E. R., Sandroni, P., & Low, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000184504.13173.ef · Cited by 160
Self-citationThe hemodynamic and neurohumoral phenotype of postural tachycardia syndrome
Garland, E. M., Raj, S. R., Black, B. K., Harris, P. A., & Robertson, D. (2007) · Neurology · doi:10.1212/01.wnl.0000267663.05398.40 · Cited by 159
Endurance Exercise Training in Orthostatic Intolerance
Winker, R., Barth, A., Bidmon, D., Ponocny, I., Weber, M., Mayr, O., Robertson, D., Diedrich, A., Maier, R., Pilger, A., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000156540.25707.af · Cited by 156
The Postural Tachycardia Syndrome: A Concise Guide to Diagnosis and Management
Grubb, B. P., Kanjwal, Y., & KOSINSKI, D. J. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.00318.x · Cited by 154
FOUAD, F. M., TADENA-THOME, L., BRAVO, E. L., & TARAZI, R. C. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-298 · Cited by 154
Physical manoeuvres for combating orthostatic dizziness in autonomic failure
van Lieshout, J. J., ten Harkel, A. D. J., & Wieling, W. (1992) · The Lancet · doi:10.1016/0140-6736(92)90932-s · Cited by 153
Orthostatic intolerance in the chronic fatigue syndrome
Schondorf, R., Benoit, J., Wein, T., & Phaneuf, D. (1999) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(98)00177-5 · Cited by 141
Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension
Denq, J.-C., Opfer-Gehrking, T. L., Giuliani, M., Felten, J., Convertino, V. A., & Low, P. A. (1997) · Clinical Autonomic Research · doi:10.1007/bf02267725 · Cited by 138
Self-citationStewart, J. M. (2002) · Circulation · doi:10.1161/01.cir.0000016348.55378.c4 · Cited by 138
Six‐month and one‐year followup of 23 weeks of aerobic exercise for individuals with fibromyalgia
Gowans, S. E., deHueck, A., Voss, S. E., Silaj, A., & Abbey, S. E. (2004) · Arthritis Care & Research · doi:10.1002/art.20828 · Cited by 132
Dysautonomia in mitral valve prolapse
Coghlan, H. C., Phares, P., Cowley, M. J., Copley, D. P., & James, T. N. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90397-8 · Cited by 125
Adrenergic and Vagal Baroreflex Sensitivity in Autonomic Failure
Schrezenmaier, C., Singer, W., Swift, N. M., Sletten, D. M., Tanabe, J., & Low, P. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.381 · Cited by 115
Self-citationLow, P. A., Opfer-Gehrking, T. L., Textor, S. C., Schondorf, R., Suarez, G. A., Fealey, R. D., & Camilleri, M. (1994) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)90008-6 · Cited by 105
Self-citationEffect of age on adrenergic and vagal baroreflex sensitivity in normal subjects
Huang, C., Sandroni, P., Sletten, D. M., Weigand, S. D., & Low, P. A. (2007) · Muscle & Nerve · doi:10.1002/mus.20853 · Cited by 101
Self-citationBRADY, P. A., LOW, P. A., & SHEN, W. K. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00227.x · Cited by 98
Self-citationMasuki, S., Eisenach, J. H., Johnson, C. P., Dietz, N. M., Benrud-Larson, L. M., Schrage, W. G., Curry, T. B., Sandroni, P., Low, P. A., & Joyner, M. J. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00927.2006 · Cited by 91
Self-citationBouvette, C. M., McPhee, B. R., Opfer‐Gehrking, T. L., & Low, P. A. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.9.847 · Cited by 89
Self-citationOrthostatic Disorders of the Circulation
Streeten, D. H. P. (1987) · Springer eBooks · doi:10.1007/978-1-4684-8962-0 · Cited by 70
The Postural Tachycardia Syndrome (PoTS)
Mathias, C. J., Owens, A. P., & Iodice, V. (2021) · Springer eBooks · doi:10.1007/978-3-030-62263-3_20 · Cited by 70
Sympathotonic orthostatic hypotension
Hoeldtke, R. D., Dworkin, G. E., Gaspar, S. R., & Israel, B. C. (1989) · Neurology · doi:10.1212/wnl.39.1.34 · Cited by 69
Gordon, V. M., Opfer-Gehrking, T. L., Novak, V., & Low, P. A. (2000) · Clinical Autonomic Research · doi:10.1007/bf02291387 · Cited by 69
Self-citationJordan, J., Shannon, J. R., Diedrich, A., Black, B. K., & Robertson, D. (2002) · Hypertension · doi:10.1161/hy1201.097202 · Cited by 69
VanDenbossche, J., Seelye, J. G., & Zielinski, B. S. (2008) · Brain Behavior and Evolution · doi:10.1159/000113382 · Cited by 66
Acetylcholinesterase Inhibition in Patients With Orthostatic Intolerance
Singer, W., Opfer-Gehrking, T. L., Nickander, K. K., Hines, S. M., & Low, P. A. (2006) · Journal of Clinical Neurophysiology · doi:10.1097/01.wnp.0000229946.01494.4c · Cited by 60
Self-citationHow to manage patients with inappropriate sinus tachycardia
Shen, W. K. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.05.002 · Cited by 59
Self-citationOrthostatic Disorders of the Circulation. Mechanisms, Manifestations, and Treatment.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-269_2 · Cited by 48
The value of autonomic testing in postural tachycardia syndrome
Al-Shekhlee, A., Lindenberg, J. R., Hachwi, R. N., & Chelimsky, T. C. (2005) · Clinical Autonomic Research · doi:10.1007/s10286-005-0282-7 · Cited by 41
Grubb, B. P. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00575.x · Cited by 38
Cited by
Sorted by citations
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
Self-citationFatigue in neurological disorders
Chaudhuri, A., & Behan, P. O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15794-2 · Cited by 1,297
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,312
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
Self-citation2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.004 · Cited by 478
Self-citation
Metadata
- Authors
- LOW, P. A., SANDRONI, P., JOYNER, M., & SHEN, W.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Cardiovascular Electrophysiology
- Publisher
- Wiley
- Published
- 2009-02-20
- Volume
- 20
- Issue
- 3
- Pages
- 352-358
- ISSN
- 1045-3873 (ISSN-L)
- 1540-8167
- PMC
- PMC3904426
- OpenAlex
- W2061811312
- Semantic Scholar
- b3c6cc27a108a5fd3d5e0f51d71fd0fbfe8a7184
- Cited by
- 358
- References
- 48
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 21 · 2023: 19 · 2022: 27 · 2021: 18 · 2020: 32 · 2019: 19 · 2018: 20 · 2017: 25 · 2016: 17 · 2015: 25 · 2014: 22 · 2013: 18 · 2012: 21
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Cardiovascular Electrophysiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Institutes of Health (n01ns032352-003)
- National Institute of Neurological Disorders and Stroke (P01NS044233, P50NS032352, NS-44233, N01 NS032352)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- postural orthostatic tachycardia syndrome, orthostatic intolerance, heart rate increase, peripheral denervation, hypovolemia, venous pooling, hyperadrenergic state, head-up tilt, volume status, high-salt diet, postural training, beta-receptor antagonists, vasoconstrictors, psychological factors
- MeSH terms
- Humans, Postural Orthostatic Tachycardia Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
